Codexis (CDXS) Receivables (2010 - 2026)
Codexis (CDXS) recorded quarterly Receivables of $8.9 million in Q1 2026, down 15.42% quarter-over-quarter from $10.5 million in Q4 2025, and down 13.72% on a YoY basis from $10.3 million in Q1 2025.
Codexis (CDXS) Receivables (2010 - 2026) Analysis & Trends
Codexis' Receivables history runs 17 years deep, the most recent figure standing at $8.9 million for Q1 2026.
- In Q1 2026, Receivables fell 13.72% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $8.9 million (down 13.72% YoY), while the FY2025 annual figure was $10.5 million, down 51.48% from the prior year.
- Receivables was $8.9 million for Q1 2026 at Codexis, down from $10.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $57.5 million in Q2 2022 to a low of $8.9 million in Q1 2026.
- Historically, Receivables has averaged $23.7 million across 5 years, with a median of $19.7 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Receivables surged 136.92% in 2022, then tumbled 66.98% in 2023.
- A 5-year view of Receivables shows it stood at $38.9 million in 2022, then decreased by 23.35% to $29.8 million in 2023, then slipped by 27.48% to $21.6 million in 2024, then sank by 51.48% to $10.5 million in 2025, then decreased by 15.42% to $8.9 million in 2026.
- The last three Receivables figures came in at $8.9 million (Q1 2026), $10.5 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 8.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.88 Mn |
| Dec 31, 2025 | 10.50 Mn |
| Sep 30, 2025 | 11.73 Mn |
| Jun 30, 2025 | 15.59 Mn |
| Mar 31, 2025 | 10.29 Mn |
| Dec 31, 2024 | 21.64 Mn |
| Sep 30, 2024 | 21.33 Mn |
| Jun 30, 2024 | 17.93 Mn |
| Mar 31, 2024 | 19.66 Mn |
| Dec 31, 2023 | 29.83 Mn |
| Sep 30, 2023 | 24.75 Mn |
| Jun 30, 2023 | 19.50 Mn |
| Mar 31, 2023 | 17.73 Mn |
| Dec 31, 2022 | 38.92 Mn |
| Sep 30, 2022 | 24.02 Mn |
| Jun 30, 2022 | 57.46 Mn |
| Mar 31, 2022 | 53.70 Mn |
| Dec 31, 2021 | 46.21 Mn |
| Sep 30, 2021 | 35.84 Mn |
| Jun 30, 2021 | 48.78 Mn |